.jpg?itok=LooO274g)
Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an assistant professor of oncology for Johns Hopkins University School of Medicine. Dr. Levy is board certified in medical oncology and hematology by the American Board of Internal Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital.
2020 CBPD LEVY - CASE 1 - Timing and Treatment for 48 YO Male with EGFR NSCLC High PDL1
2020 Case Based Panel Discussions, Dr. Ben LEVY - CASE 1 - Timing and Treatment for 48 year old male with high PDL1, lung mass and disseminated cancer across both lungs, and no real comorbidities
Image
For this series of Case Based Panel Discussions, Dr. Benjamin Levy is joined by Dr. Stephen Liu and Dr. Julie Brahmer to discuss treatment for specific cases in Lung Cancer.
Dr. Levy is Associate Professor of Oncology and Clinical Director of Medical Oncology and Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, and sits on the board of GRACE. Dr. Liu is Associate Professor of Medicine and Director of Thoracic Oncology and Director of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. Dr. Julie Brahmer is Director of the Thoracic Oncology Program and Professor of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
For this series, the doctors review cases related to EGFR positive NSCLC.
In this video, the case discussion surrounds timing and treatment for a 48 year old male with high PDL1, lung mass and disseminated cancer across both lungs, and no real comorbidities.
We thank AstraZeneca Merck Genentech Takeda and Lilly for their support!
To join the conversation, visit https://cancergrace.org/forum.
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Video
En este video, la Dra. Velázquez Mañana analiza las mutaciones del EGFR, los diferentes subtipos de cáncer de pulmón y cómo determinar cuál es el mejor tratamiento en general.
To watch the complete playlist, click here.
Special thanks to Genentech, BMS, Takeda, Johnson & Johnson, and Daiichi-Sankyo for their sponsorship of this program.
Article
Head and neck cancers linked to human papillomavirus (HPV) are very different from those caused by tobacco or alcohol. The good news is that HPV-positive cancers usually respond better to treatment and often have better outcomes.
Image
 (1280 x 350 px) (1280 x 250 px).png)
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Online Community
Recent Comments
The information you share is…
By LibbieRohan on
Hello Natalieaster, Welcome to Grace. I hope your stay with us is short, but we are always here to answer, listen and share.
Since your doctor didn't seem too worried...